课题基金 / 基金详情

SORIVUDINE EFFECT ON DIHYDROPYRIMIDINE DEHYDROGENASE IN BLOOD OF ZOSTER PATIENTS

SORIVUDINE EFFECT ON DIHYDROPYRIMIDINE DEHYDROGENASE IN BLOOD OF ZOSTER PATIENTS
索利夫定对带状疱疹患者血液二氢嘧啶脱氢酶的影响
批准号:
6246333
负责人:
STEPHEN K TYRING
金额:
$2.71万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-01-06 至 1997-11-30

项目摘要

项目成果

STEPHEN K TYRING的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This is an open label study of the effect of Sorivudine in the treatment of acute localized zoster and the effect of this drug on levels of dihydropyrimidine dehydrogenase found in leukocytes. During the ten days of therapy, patients will be seen on days 1, 2, 5, 7, and 10; following treatment they will be seen on days 14, 17, 24, 28,31, and 38.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic Resistance to Oncogenic Human Papillomaviruses
Genetic Resistance to Oncogenic Human Papillomaviruses
ABT 606 VS ACYCLOVIR FOR TREATMENT OF HERPES ZOSTER
STUDY OF ORAL LOBUCAVIR IN PATIENTS WITH RECURRENT GENITAL HERPES
海外基金